ChromoTek is a biotech company offering a new class of immunologic research tools derived from single domain camel antibodies for cell biology and proteomics.
ChromoTek is a biotech company offering a new class of immunologic research tools derived from single domain camel antibodies for cell biology and proteomics.
Cellecta is a biotech company developing advanced high-throughput genetic screen technologies for the discovery and functional characterization of novel therapeutic targets and drugs.
BioNano Genomics aims to bring full genome understanding to the entire scientific community through its unique Irys System. Irys is based on NanoChannels uniformly stretching and linearizing DNA to map the genome unlike any other solution. Irys System uses high-resolution, single-molecule imaging of labeled, long DNA to explore the genome.
TriLink is biotech company supplying RNA and DNA oligonucleotides for pre-clinical research and specialized in highly modified oligos, including RNA oligonucleotides and derivatives (2′ Fluoro RNA, 2′ O-Methyl RNA, etc…).
Protea is a leader in the emerging field of Bioanalytics by developing new technology for the identification, characterization, and quantification of biologically-important molecules for basic research, pharmaceutical development, and diagnostic applications.
Denovix is a biotech company developing high quality Spectrophotometers and Fluorometers.
Aptagen is a biotech company proposing aptamer products and services as reagents, diagnostic and biomarker discovery tools. Aptamers are used in drug discovery, targeted delivery for therapeutics or bioindustrial applications.
CLC Bio is a world’s leading bioinformatics software developer company providing an analysis platform where both desktop and server software are integrated for best performance.
Abnova is one of the world’s largest antibody manufacturer, able to generate 300 mouse monoclonal antibodies and 200 rabbit polyclonal antibodies per month.
Kite Pharma is a biotech company developing a pipeline of product candidates using its therapeutic platform: engineered Autologous Cell Therapy (eACT).